Vistagen Therapeutics, Inc. (VTGN)
0.2434
+0.01
(+3.35%)
USD |
NASDAQ |
Sep 10, 15:58
Vistagen Therapeutics Total Assets (Quarterly) : 35.74M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.74M |
| March 31, 2026 | 48.56M |
| December 31, 2025 | 65.06M |
| September 30, 2025 | 80.93M |
| June 30, 2025 | 68.92M |
| December 31, 2024 | 92.31M |
| September 30, 2024 | 102.50M |
| June 30, 2024 | 113.55M |
| March 31, 2024 | 123.65M |
| December 31, 2023 | 131.07M |
| September 30, 2023 | 42.20M |
| June 30, 2023 | 15.03M |
| March 31, 2023 | 21.09M |
| December 31, 2022 | 29.71M |
| September 30, 2022 | 40.70M |
| June 30, 2022 | 58.73M |
| March 31, 2022 | 74.64M |
| December 31, 2021 | 90.54M |
| September 30, 2021 | 100.50M |
| June 30, 2021 | 103.91M |
| March 31, 2021 | 108.28M |
| December 31, 2020 | 109.27M |
| September 30, 2020 | 20.27M |
| June 30, 2020 | 6.167M |
| March 31, 2020 | 5.772M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.331M |
| September 30, 2019 | 8.736M |
| June 30, 2019 | 12.95M |
| March 31, 2019 | 14.01M |
| December 31, 2018 | 7.522M |
| September 30, 2018 | 8.889M |
| June 30, 2018 | 8.255M |
| March 31, 2018 | 11.28M |
| December 31, 2017 | 14.24M |
| September 30, 2017 | 2.618M |
| June 30, 2017 | 2.437M |
| March 31, 2017 | 3.712M |
| December 31, 2016 | 5.876M |
| September 30, 2016 | 7.023M |
| June 30, 2016 | 8.758M |
| March 31, 2016 | 0.9898M |
| December 31, 2015 | 2.012M |
| September 30, 2015 | 1.932M |
| June 30, 2015 | 1.744M |
| March 31, 2015 | 0.2697M |
| December 31, 2014 | 0.2594M |
| September 30, 2014 | 0.5798M |
| June 30, 2014 | 0.9628M |
| March 31, 2014 | 0.4618M |
| December 31, 2013 | 0.527M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.26M |
| Shareholders Equity (Quarterly) | 24.48M |
| Debt to Equity Ratio | 0.032 |
| Current Ratio | 3.066 |
| Net Debt Paydown Yield | 1.85% |